Lithium Versus Cariprazine in the Acute Phase Treatment of Bipolar Depression (DUAG9) | MicrobiomeTrials← Back to trialsNCT05913947
Lithium Versus Cariprazine in the Acute Phase Treatment of Bipolar Depression (DUAG9)
RecruitingPHASE4INTERVENTIONAL
Trial Details
Start: 2022-12-13Est. Completion: 2028-09-01
Enrollment target: 122 participants Locations- Aalborg University Hospital, Aalborg, Denmark
Other microbiome trials you might be interested in
Bipolar I Disorder
Phase II study for patients with Bipolar 1 Disorder experiencing major depressive episode. Patient eligible for enrollme…
Bentonville, United StatesEst. completion Feb 2028
Major Depressive DisorderBipolar DisorderSchizophrenia
This prospective, open-label clinical trial aims to compare a novel "Venous Tourniquet with Regional Low-Dose Sugammadex…
Istanbul, Turkey (Türkiye)Est. completion Nov 30, 2026
Phase 3
Recruiting
DepressionBipolar I Disorder
Bipolar disorder is a severe chronic mood disorder that affects up to 4% of the adult population and 1.8% of the pediatr…
Bentonville, United StatesEst. completion Mar 2027